DK1776358T3 - Substituerede propenylpiperazinderivater som nye inhibitorer af histondeacetylase - Google Patents

Substituerede propenylpiperazinderivater som nye inhibitorer af histondeacetylase

Info

Publication number
DK1776358T3
DK1776358T3 DK05777776T DK05777776T DK1776358T3 DK 1776358 T3 DK1776358 T3 DK 1776358T3 DK 05777776 T DK05777776 T DK 05777776T DK 05777776 T DK05777776 T DK 05777776T DK 1776358 T3 DK1776358 T3 DK 1776358T3
Authority
DK
Denmark
Prior art keywords
propenylpiperazine
derivatives
substituted
histone deacetylase
novel inhibitors
Prior art date
Application number
DK05777776T
Other languages
Danish (da)
English (en)
Inventor
Brandt Sven F A Van
Emelen Kristof Van
Patrick R Angibaud
Laurence F B Marconnet-Decrane
Janine Janssen Pharmaceut Arts
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39294123&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1776358(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK1776358T3 publication Critical patent/DK1776358T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK05777776T 2004-07-28 2005-07-25 Substituerede propenylpiperazinderivater som nye inhibitorer af histondeacetylase DK1776358T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04077171 2004-07-28
US59235704P 2004-07-29 2004-07-29
PCT/EP2005/053611 WO2006010749A2 (en) 2004-07-28 2005-07-25 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase

Publications (1)

Publication Number Publication Date
DK1776358T3 true DK1776358T3 (da) 2009-09-07

Family

ID=39294123

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05777776T DK1776358T3 (da) 2004-07-28 2005-07-25 Substituerede propenylpiperazinderivater som nye inhibitorer af histondeacetylase

Country Status (25)

Country Link
EP (1) EP1776358B1 (de)
JP (1) JP5279268B2 (de)
KR (1) KR101282833B1 (de)
CN (1) CN1993356B (de)
AR (1) AR050189A1 (de)
AT (1) ATE432274T1 (de)
AU (1) AU2005266311B2 (de)
BR (1) BRPI0513891B8 (de)
CA (1) CA2572971C (de)
CY (1) CY1110358T1 (de)
DE (1) DE602005014646D1 (de)
DK (1) DK1776358T3 (de)
EA (1) EA011932B1 (de)
ES (1) ES2327253T3 (de)
HR (1) HRP20090439T1 (de)
IL (1) IL180961A0 (de)
MX (1) MX2007001119A (de)
MY (1) MY142831A (de)
NO (1) NO20071117L (de)
NZ (1) NZ552758A (de)
PL (1) PL1776358T3 (de)
PT (1) PT1776358E (de)
SI (1) SI1776358T1 (de)
TW (1) TWI394752B (de)
WO (1) WO2006010749A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2306880T3 (es) 2002-03-13 2008-11-16 Janssen Pharmaceutica Nv Derivados de sulfonilamino como inhibidores novedosos de la histona desacetilasa.
EA007270B1 (ru) 2002-03-13 2006-08-25 Янссен Фармацевтика Н.В. Пиперазинил-, пиперидинил- и морфолинилпроизводные как новые ингибиторы гистондеацетилазы
AU2003218737B2 (en) 2002-03-13 2008-04-10 Janssen Pharmaceutica N.V. Inhibitors of histone deacetylase
PL1781639T3 (pl) 2004-07-28 2012-07-31 Janssen Pharmaceutica Nv Podstawione pochodne indolilo-alkiloaminowe jako nowe inhibitory deacetylazy histonowej
AU2006248938B2 (en) 2005-05-18 2011-09-29 Janssen Pharmaceutica N.V. Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
WO2007049262A1 (en) * 2005-10-27 2007-05-03 Berand Limited Methods and compositions for the promotion of neuronal growth and the treatment of asociality and affective disorders
US8101616B2 (en) 2006-01-19 2012-01-24 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
DE602007001190D1 (de) 2006-01-19 2009-07-09 Janssen Pharmaceutica Nv Aminophenylderivate als neue inhibitoren von histondeacetylase
CA2635015C (en) 2006-01-19 2014-06-03 Janssen Pharmaceutica N.V. Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
JP5247470B2 (ja) * 2006-01-19 2013-07-24 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼのインヒビターとしてのピリジン及びピリミジン誘導体
EP1839656A1 (de) * 2006-03-31 2007-10-03 TopoTarget Germany AG Verwendung von Valproicsäure zur topischen Verhandung von mild bis mässig Akne Vulgaris
BRPI0817897A2 (pt) 2007-11-02 2019-09-24 Methylgene Inc composto, composição, e, métodos de inibição da atividade hdac, e de tratamento de uma doença responsiva a um inibidor de atividade hdac
CN101723896B (zh) * 2009-11-03 2012-10-31 山东大学 酪氨酸衍生物类组蛋白去乙酰化酶抑制剂及其应用
WO2012117421A1 (en) 2011-03-02 2012-09-07 Orchid Research Laboratories Ltd Histone deacetylase inhibitors
KR101419836B1 (ko) * 2012-05-10 2014-07-16 서울대학교산학협력단 Δ5-2-옥소피페라진 유도체를 포함하는 중간엽 줄기세포의 연골세포로의 분화 유도용 조성물
KR101586045B1 (ko) 2013-07-30 2016-01-15 충북대학교 산학협력단 신규 페닐티아졸 기반 히드록삼산 및 이를 유효성분으로 포함하는 항암용 조성물
KR102132078B1 (ko) 2018-09-20 2020-07-08 원광대학교산학협력단 방향족 화합물, 아민 및 친핵체를 이용한 3가지 성분 반응으로 1-에틸-4-페닐피페라진 유도체를 제조하는 방법
KR102730905B1 (ko) 2022-05-03 2024-11-15 충북대학교 산학협력단 신규한 n-히드록시프로펜아미드 화합물 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물
KR102870919B1 (ko) 2022-05-03 2025-10-20 충북대학교 산학협력단 신규한 n-히드록시프로펜아미드 화합물 및 이를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
AU2003218737B2 (en) * 2002-03-13 2008-04-10 Janssen Pharmaceutica N.V. Inhibitors of histone deacetylase
EA007270B1 (ru) * 2002-03-13 2006-08-25 Янссен Фармацевтика Н.В. Пиперазинил-, пиперидинил- и морфолинилпроизводные как новые ингибиторы гистондеацетилазы
BR0308908A (pt) * 2002-04-03 2005-01-04 Topotarget Uk Ltd Composto, composição, uso de um composto, e, métodos para inibir a hdac em uma célula, para o tratamento de uma condição mediada pela hdac, de um condição proliferativa, de câncer e de psorìase

Also Published As

Publication number Publication date
BRPI0513891A (pt) 2008-05-20
DE602005014646D1 (de) 2009-07-09
CY1110358T1 (el) 2015-04-29
EP1776358B1 (de) 2009-05-27
MX2007001119A (es) 2007-03-15
AU2005266311A1 (en) 2006-02-02
HK1106236A1 (en) 2008-03-07
BRPI0513891B1 (pt) 2020-09-29
TW200616998A (en) 2006-06-01
ATE432274T1 (de) 2009-06-15
PL1776358T3 (pl) 2009-10-30
CA2572971A1 (en) 2006-02-02
PT1776358E (pt) 2009-08-13
KR101282833B1 (ko) 2013-07-08
IL180961A0 (en) 2007-07-04
MY142831A (en) 2011-01-14
AU2005266311B2 (en) 2011-08-11
KR20070043978A (ko) 2007-04-26
NZ552758A (en) 2009-08-28
SI1776358T1 (sl) 2009-10-31
HRP20090439T1 (hr) 2009-09-30
EP1776358A2 (de) 2007-04-25
NO20071117L (no) 2007-02-27
CA2572971C (en) 2013-01-15
TWI394752B (zh) 2013-05-01
AR050189A1 (es) 2006-10-04
ES2327253T3 (es) 2009-10-27
BRPI0513891B8 (pt) 2021-05-25
EA200700143A1 (ru) 2007-06-29
JP2008508234A (ja) 2008-03-21
JP5279268B2 (ja) 2013-09-04
EA011932B1 (ru) 2009-06-30
CN1993356B (zh) 2010-10-27
CN1993356A (zh) 2007-07-04
WO2006010749A3 (en) 2006-06-08
WO2006010749A2 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
DK1485348T3 (da) Carbonylamino-derivater som nye inhibitorer af histandeacetylase
DK1485354T3 (da) Sulfonylamino-derivater som nye inhibitorer af histandeacetylase
DK1485365T3 (da) Sulfonyl-derivater som nye inhibitorer af histandeacetylase
DK1485353T3 (da) Nye inhibitorer af histondeacetylase
DK1981875T3 (da) Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase
EP1789381A4 (de) Histondeacetylase-hemmer
NO20044444L (no) Benzamidderivater nyttige som histondeacetylase inhibitorer
DK1501508T3 (da) Inhibitorer af histondeatylase
DK1848430T3 (da) Nye benzylamin-derivativer som cetp-inhibitors
DK2091945T3 (da) Nye inhibitorer af glutaminylcyclase
DK2081895T3 (da) Hydrobenzamidderivater som hæmmere af hsp90
DK2086960T3 (da) Nye inhibitorer af glutaminylcyclase.
DK1485378T3 (da) Piperazinyl-, piperidinyl- og morpholinylderivater som nye inhibitorer af histondeacetylase
DK1877379T3 (da) Hydroxybenzamidderivater og anvendelse heraf som inhibitorer af hsp90
BRPI0716838A2 (pt) combinaÇÕes de inibidores de histona deacetilase especÍfica de classe i com inibidores de proteosome
DK1979328T3 (da) Pyridin- og pyrimidinderivater i deres egenskab af histondeacetylasehæmmere
EP2265590A4 (de) Selektive histondeacetylase-hemmer
EP1991226A4 (de) Histondeacetylase-hemmer
DK2315756T3 (da) 1,2,5-oxadiazoler som inhibitorer af indolamin-2,3-dioxygenase
DK1789041T3 (da) Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer
BRPI0817860A2 (pt) inibidores de histona deacetilase
IL180961A0 (en) Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase
EP2010168A4 (de) Histondeacetylase-inhibitoren
DK1797042T3 (da) Indozolonderivater som 11B-HSD1-inhibitorer
ZA200700763B (en) Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase